Less than a year after that plant passed an inspection in 2012, Ranbaxy admitted that some of the millions of generic Lipitor pills already dispensed in the U.S. were suffused with tiny shards of ...

A new book investigates the history of unsafe and deceptive practices by some generic-drug manufacturers, and explains why U.S. regulators struggle to keep up with a global industry.